Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 87,292 | 94,367 | 89,959 | 121,424 | 204,949 |
| Marketable Securities | 45,558 | 53,149 | 83,506 | 94,789 | 60,004 |
| Receivables | 12,488 | 12,277 | 14,065 | 14,001 | 12,220 |
| Other current assets | 2,311 | 40,301 | 53,779 | 57,015 | 43,654 |
| TOTAL | $154,729 | $204,636 | $249,870 | $297,172 | $333,180 |
| Non-Current Assets | |||||
| PPE Net | 12,531 | 13,236 | 13,657 | 16,003 | 16,583 |
| Investments And Advances | 148,250 | 94,108 | 67,537 | 45,086 | 35,822 |
| Other Non-Current Assets | 45,251 | 43,379 | 43,755 | 44,848 | 43,666 |
| TOTAL | $206,032 | $150,723 | $124,949 | $105,937 | $96,071 |
| Total Assets | $360,761 | $355,359 | $374,819 | $403,109 | $429,251 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 9,012 | 16,940 | 12,530 | 6,941 |
| Accounts payable and accrued liabilities | 3,074 | 1,510 | 3,098 | 8,900 | 10,702 |
| Accrued Expenses | 17,000 | 19,813 | 19,634 | 18,297 | 21,804 |
| TOTAL | $32,624 | $44,201 | $58,587 | $66,082 | $67,127 |
| Non-Current Liabilities | |||||
| Long Term Debt | 396,125 | 384,161 | 371,359 | 375,570 | 375,069 |
| Deferred Revenues | 24 | 98 | 98 | 2,902 | 5,690 |
| Other Non-Current Liabilities | 281,617 | 278,146 | 283,136 | 284,729 | 287,100 |
| TOTAL | $677,946 | $662,608 | $654,805 | $660,619 | $662,498 |
| Total Liabilities | $710,570 | $706,809 | $713,392 | $726,701 | $729,625 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,427 | 76,115 | 74,697 | 73,698 | 73,470 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -1,760,180 | -1,751,989 | -1,726,043 | -1,694,009 | -1,658,701 |
| Other shareholders' equity | -45 | -28 | 0 | 14 | 8 |
| TOTAL | $-349,809 | $-351,450 | $-338,573 | $-323,592 | $-300,374 |
| Total Liabilities And Equity | $360,761 | $355,359 | $374,819 | $403,109 | $429,251 |